Literature DB >> 20350496

Risk groups and other target groups - preliminary ECDC guidance for developing influenza vaccination recommendations for the season 2010-11.

H Nokleby1, A Nicoll.   

Abstract

Providing guidance on risk and target groups for seasonal influenza immunisation is difficult for the 2010-11 season since there is no experience with the new influenza A(H1N1) virus in its seasonal form. Arguments exist for offering immunisation to people with chronic illness and older people, and also for other risk and target groups including pregnant women. A more rigorous approach is being developed to produce annual evidence-based guidance on risk and target groups for influenza vaccination.

Entities:  

Mesh:

Year:  2010        PMID: 20350496

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  9 in total

1.  Sudden death of an immunocompetent young adult caused by novel (swine origin) influenza A/H1N1-associated myocarditis.

Authors:  Georg Gdynia; Paul Schnitzler; Eva Brunner; Reinhard Kandolf; Hendrik Bläker; Edith Daum; Philipp Schnabel; Peter Schirmacher; Wilfried Roth
Journal:  Virchows Arch       Date:  2011-01-14       Impact factor: 4.064

Review 2.  Current evidence on intradermal influenza vaccines administered by Soluvia™ licensed micro injection system.

Authors:  Giancarlo Icardi; Andrea Orsi; Antonella Ceravolo; Filippo Ansaldi
Journal:  Hum Vaccin Immunother       Date:  2012-01-01       Impact factor: 3.452

3.  Factors associated with uptake of influenza vaccine in people aged 50 to 64 years in Hong Kong: a case-control study.

Authors:  May Ps Yeung; Stephen Kam-Cheung Ng; Edmond Tak Fai Tong; Stephen Sek-Kam Chan; Richard Coker
Journal:  BMC Public Health       Date:  2015-07-07       Impact factor: 3.295

4.  Public health and economic impact of seasonal influenza vaccination with quadrivalent influenza vaccines compared to trivalent influenza vaccines in Europe.

Authors:  Mathieu Uhart; Hélène Bricout; Emilie Clay; Nathalie Largeron
Journal:  Hum Vaccin Immunother       Date:  2016-05-11       Impact factor: 3.452

5.  Influenza-like illness and antimicrobial prescribing in Australian general practice from 2015 to 2017: a national longitudinal study using the MedicineInsight dataset.

Authors:  Carla De Oliveira Bernardo; David Gonzalez-Chica; Nigel Stocks
Journal:  BMJ Open       Date:  2019-05-01       Impact factor: 2.692

6.  Influenza A/H1N1 MF59 adjuvanted vaccine in pregnant women and adverse perinatal outcomes: multicentre study.

Authors:  F Rubinstein; P Micone; A Bonotti; V Wainer; A Schwarcz; F Augustovski; A Pichon Riviere; A Karolinski
Journal:  BMJ       Date:  2013-02-04

7.  Effectiveness of seasonal influenza vaccinations against laboratory-confirmed influenza-associated infections among Singapore military personnel in 2010-2013.

Authors:  Hin Peow Ho; Xiahong Zhao; Junxiong Pang; Mark I-C Chen; Vernon J M Lee; Li Wei Ang; Raymond V Tzer Pin Lin; Christine Q Gao; Li Yang Hsu; Alex R Cook
Journal:  Influenza Other Respir Viruses       Date:  2014-05-14       Impact factor: 4.380

8.  Impact of patient characteristics and treatment procedures on hospitalization cost and length of stay in Japanese patients with influenza: A structural equation modelling approach.

Authors:  Rosarin Sruamsiri; Sameh Ferchichi; Aurélien Jamotte; Mondher Toumi; Hiroshi Kubo; Jörg Mahlich
Journal:  Influenza Other Respir Viruses       Date:  2017-10-27       Impact factor: 4.380

Review 9.  Rapid qualitative review of ethical issues surrounding healthcare for pregnant women or women of reproductive age in epidemic outbreaks.

Authors:  Patrik Hummel; Abha Saxena; Corinna Klingler
Journal:  Epidemiol Health       Date:  2018-01-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.